← FDA Drug Approvals (Drugs@FDA)

ANJESO

NDA · New Drug Application · Sponsor: BAUDAX · Approved 2020-02-20

Drug application

FDA Application #

NDA210583

Application type

New Drug Application

Brand name

ANJESO

Generic name

Meloxicam

Active ingredients

MELOXICAM

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

Discontinued

Sponsor

BAUDAX

First approval

2020-02-20

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown